12-4288600-G-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001759.4(CCND2):​c.572-242G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.182 in 152,106 control chromosomes in the GnomAD database, including 2,872 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.18 ( 2872 hom., cov: 30)

Consequence

CCND2
NM_001759.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.279

Publications

8 publications found
Variant links:
Genes affected
CCND2 (HGNC:1583): (cyclin D2) The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with CDK4 or CDK6 and functions as a regulatory subunit of the complex, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. Knockout studies of the homologous gene in mouse suggest the essential roles of this gene in ovarian granulosa and germ cell proliferation. High level expression of this gene was observed in ovarian and testicular tumors. Mutations in this gene are associated with megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3). [provided by RefSeq, Sep 2014]
CCND2 Gene-Disease associations (from GenCC):
  • megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 12-4288600-G-C is Benign according to our data. Variant chr12-4288600-G-C is described in ClinVar as Benign. ClinVar VariationId is 1225707.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.233 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCND2NM_001759.4 linkc.572-242G>C intron_variant Intron 3 of 4 ENST00000261254.8 NP_001750.1 P30279-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCND2ENST00000261254.8 linkc.572-242G>C intron_variant Intron 3 of 4 1 NM_001759.4 ENSP00000261254.3 P30279-1
ENSG00000285901ENST00000674624.1 linkn.572-242G>C intron_variant Intron 3 of 9 ENSP00000501898.1 A0A6Q8PFP0

Frequencies

GnomAD3 genomes
AF:
0.183
AC:
27750
AN:
151988
Hom.:
2876
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.104
Gnomad AMI
AF:
0.340
Gnomad AMR
AF:
0.144
Gnomad ASJ
AF:
0.230
Gnomad EAS
AF:
0.0651
Gnomad SAS
AF:
0.176
Gnomad FIN
AF:
0.232
Gnomad MID
AF:
0.247
Gnomad NFE
AF:
0.236
Gnomad OTH
AF:
0.196
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.182
AC:
27742
AN:
152106
Hom.:
2872
Cov.:
30
AF XY:
0.180
AC XY:
13374
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.104
AC:
4318
AN:
41506
American (AMR)
AF:
0.143
AC:
2192
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.230
AC:
798
AN:
3472
East Asian (EAS)
AF:
0.0653
AC:
338
AN:
5180
South Asian (SAS)
AF:
0.175
AC:
845
AN:
4818
European-Finnish (FIN)
AF:
0.232
AC:
2451
AN:
10554
Middle Eastern (MID)
AF:
0.231
AC:
68
AN:
294
European-Non Finnish (NFE)
AF:
0.236
AC:
16014
AN:
67968
Other (OTH)
AF:
0.193
AC:
409
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1161
2322
3483
4644
5805
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
302
604
906
1208
1510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.101
Hom.:
160
Bravo
AF:
0.172
Asia WGS
AF:
0.0800
AC:
279
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.72
DANN
Benign
0.71
PhyloP100
-0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3217852; hg19: chr12-4397766; API